SCHEMBL11986243

SCHEMBL11986243

CC(=O)C(O)C(CC(=O)O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.42
MAPT P10636 1/20 0.37
GABRR1 P24046 2/20 0.36
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.35
GPR84 Q9NQS5 2/20 0.33
TP53 P04637 1/20 0.33
FOLH1 Q04609 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13254368 0.86 TDP1 (0.40) TDP1SMN1; SMN2SLC22A6TSHRTP53
Isocitric Acid SCHEMBL27894954 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitric Acid SCHEMBL29645996 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitric Acid SCHEMBL30700829 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitric Acid SCHEMBL6249818 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitrate SCHEMBL1289944 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitric Acid SCHEMBL12927570 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitrate SCHEMBL8373 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
Isocitric Acid SCHEMBL2794437 0.82 TDP1 (0.68) TDP1SMN1; SMN2SLC22A6MAPTGABRR1
SCHEMBL9911940 0.82 TDP1 (0.37) TDP1SMN1; SMN2TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884937-B2 Polymer compositions and methods SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2018-02-06 US disclosed
US-9850345-B2 Polycarbonate polyol compositions and methods SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-12-26 US disclosed
US-9834710-B2 Adhesive compositions and methods SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-12-05 US disclosed
US-20170051106-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-02-23 US disclosed
US-20170022319-A1 ALIPHATIC POLYCARBONATE POLYOL COMPOSITIONS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2017-01-26 US disclosed
US-9512259-B2 High strength polyurethane foam compositions and methods NOVOMER, INC. (US) 2016-12-06 US disclosed
US-20160319064-A1 POLYMER COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2016-11-03 US disclosed
US-9453100-B2 Polymer compositions and methods NOVOMER, INC. (US) 2016-09-27 US disclosed
US-20160264728-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS SAUDI ARAMCO TECHNOLOGIES COMPANY (SA) 2016-09-15 US disclosed
US-9399701-B2 Polymer compositions and methods NOVOMER, INC. (US) 2016-07-26 US disclosed
US-20140024795-A1 ALIPHATIC POLYCARBONATE POLYOLS CONTAINING SILYL GROUPS NOVOMER, INC. (US) 2014-01-23 US disclosed
US-20130281633-A1 POLYMER COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2013-10-24 US disclosed
US-20130274401-A1 ADHESIVE COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2013-10-17 US disclosed
US-20130244864-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2013-09-19 US disclosed
US-20130172482-A1 POLYMER COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2013-07-04 US disclosed
US-8470956-B2 Polycarbonate polyol compositions and methods NOVOMER, INC. (US) 2013-06-25 US disclosed
US-20130066044-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS NOVOMER, INC. (US) 2013-03-14 US disclosed
US-8247520-B2 Polycarbonate polyol compositions and methods NOVOMER, INC. (US) 2012-08-21 US disclosed
US-20110230580-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS Novomer, Inc (US) 2011-09-22 US disclosed
US-20100184643-A1 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2010-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230580-A1 POLYCARBONATE POLYOL COMPOSITIONS AND METHODS PARG, PUF60, PICALM TDP1 2850/4885SMN1; SMN2 4396/4885SLC22A6 3039/4885
US-20100184643-A1 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency EPOR, MPL, MCL1 TDP1 4797/4885SMN1; SMN2 4488/4885SLC22A6 2478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.